Comment l'IA repousse les limites de la médecine

This discussion explores the intersection of medicine and artificial intelligence, highlighting how AI is pushing boundaries in healthcare, extending human longevity, and offering personalized medical solutions. Historically, medical advancements have dramatically improved human health and life expectancy. An average person today enjoys better health than any king or emperor of past centuries. Diseases like smallpox have been eradicated through global vaccination campaigns, initiated by Edward Jenner in 1796 with a vaccine derived from cowpox, and later advanced by Louis Pasteur who discovered the principle of attenuation. Pasteur's work, including a rabies vaccine administered after exposure, cemented his status as a medical hero. Numerous other vaccines followed, significantly reducing the prevalence of diseases like typhoid, plague, diphtheria, tuberculosis, yellow fever, and polio. These achievements have eradicated many diseases that were once common. The progress in medicine is measurable through increased life expectancy and healthy life expectancy. Over the last century, life expectancy has multiplied, with a notable increase in recent decades. The cognitive abilities of older individuals have also improved significantly; for example, a study showed that 78-year-old Berliners in the 2010s had perceptual-motor processing speeds equivalent to those 25 years younger in the 1990s. Similarly, Norwegian and Finnish studies indicate that today's 60-80 year olds exhibit physical and cognitive abilities comparable to people 15-30 years younger in previous generations. This is partly attributed to reduced smoking and drinking, and increased participation in physical activity, moving away from physically demanding manual labor that used to break down bodies. This extended longevity is also evident in high-level athletes, with figures like Cristiano Ronaldo playing at 41, and tennis legends Federer, Nadal, and Djokovic maintaining top performance into their late 30s. LeBron James continues to be a statistical leader in basketball at 41, and Tom Brady played American football until 45. While life expectancy in developed countries is still rising, the rate of increase has slowed to about one year per decade, with some countries even seeing a decline. However, underdeveloped countries like Rwanda have experienced staggering increases in life expectancy, sometimes nearly a year per calendar year. Despite these advancements, the pursuit of eternal life has become a focus for some. Brian Johnson, a 48-year-old American entrepreneur, is a prominent figure in extreme biohacking. He spends $2 million annually on his "Blueprint" project, a self-experiment to slow, stop, or reverse biological aging, aiming for immortality within 15 years. His strict vegan diet, calorie restriction, rigorous exercise, and hundreds of daily biomarker measurements are part of this protocol. Johnson's reported results include a reduction in his aging rate to 0.69 years per calendar year and a 5.1-year reversal of his overall biological age after two years. He has also launched an ultra-exclusive "Immortals" protocol at $1 million per year, with a free, low-cost version planned for 2026-2027. Another concept is "Longevity Escape Velocity" (LEV), coined by biogerontologist Aubrey de Grey. LEV is the hypothetical point where medical and scientific progress adds more than one year of life expectancy for each additional year of life. This would mean that the distance to death remains constant or even decreases. While de Grey's initial estimates for reaching LEV were optimistic, he now predicts a 50% chance by 2035-2040. Ray Kurzweil, Google's director of engineering, similarly predicts immortality by 2045 through nanobots and AI. The philosophical implications of such pursuits are debated. While technological progress is generally supported, the idea of death becoming an "administered" event rather than a natural one raises concerns. The pursuit of immortality, some argue, can be seen as a rejection of natural limits and the inherent cycles of life and death, potentially leading to a loss of meaning and connection. Beyond longevity, artificial intelligence is revolutionizing medicine through personalized drug development. DeepMind's AlphaFold AI, for example, predicted the structure of nearly 200 million proteins in seconds, a feat that earned its founder the 2024 Nobel Prize in Chemistry. This advancement is crucial because a protein's 3D shape dictates its function, and incorrect folding can lead to diseases like cancer or Alzheimer's. Before AlphaFold, determining a single protein's structure was a months-long, expensive, and often unsuccessful endeavor. AlphaFold 3, an even more powerful version, predicts not only proteins but also their interactions with DNA, RNA, molecules, and drugs, making its database of 200 million protein structures freely available to researchers worldwide. This accelerates drug discovery, disease understanding, and the development of personalized vaccines. A compelling example of AI's transformative power is the story of Paul Conningham, an Australian AI entrepreneur. When his dog, Rosie, was diagnosed with late-stage mast cell cancer with a fatal prognosis, Conningham used AI to develop a personalized mRNA vaccine. He leveraged AI tools like ChatGPT, Gemini, and Grock as research assistants to understand cancer at a molecular level, learn about neoantigens, and design an mRNA vaccine. He then sequenced his dog's and the tumor's DNA, analyzed the data using bioinformatics tools, and, with AI assistance, designed the exact mRNA sequence for the vaccine. After navigating extensive administrative hurdles, the vaccine was manufactured and administered, leading to a visible regression of Rosie's tumor. This case demonstrates AI's potential to democratize complex scientific processes and accelerate personalized medical treatments, even for rare or difficult cases. The discussion concludes by emphasizing that this era marks a revolution in access to previously complex information, elevating human capabilities and forcing faster action. While AI excels at data processing, the human capacity for innovative thought remains crucial.